Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.

New botanical formula improves eye fatigue, dry eye

24 Aug 2020
Healthcare professionals: 3 ways you can relieve eye strain at work

A novel botanical combination of lutein ester, zeaxanthin, and extracts of blackcurrant, chrysanthemum, and goji berry provides protective benefits in adults with eye fatigue without changing the retinal structure, a study has shown.

The botanical formula may be used as an effective nutritional strategy in improving eye fatigue without causing serious side effects, according to the investigators.

A total of 360 participants were randomized into four groups to receive placebo and three doses of the novel formula (chewable tablets containing 6, 10, or 14 mg of lutein) once daily for 90 days. Each participant had three visits at baseline (V1), 45 days (V2), and 90 days (V3) during the study.

Those who received the botanical formula showed improvement in individual scores of eye fatigue symptoms, including eye soreness, blurred vision, dry eye, foreign body sensation, and tearing.

All three doses led to a significant decrease in the total score of eye fatigue symptoms and an increase in the visuognosis persistence time at both V2 and V3 compared with placebo. Both the 10- and 14-mg lutein formula groups had improved tear secretion at V3 compared with placebo, based on the Schirmer test.

According to the keratography results, the first tear break-up time, average tear break-up time, and tear meniscus height were significantly increased following formula intervention.

Furthermore, all three doses of the botanical formula significantly increased the macular pigment optical density at V2 and V3 compared with placebo. On the other hand, optical coherence tomography did not show a significant difference in retinal thickness and retinal volume across all groups at both visits.

Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.